Register now for “A Single Mouse Approach: Pharmacokinetic and Pharmacodynamic Bioanalysis Using the Gyrolab xP Immunoassay Platform,” a complimentary, educational webinar sponsored by Gyros, featuring Ann-Charlott Steffen of AstraZeneca and Mark Cameron and Andreea Halford of MPI Research, on Wednesday, March 21, 2012, from 11 am to 12:30 pm ET.
- The cutting-edge developments associated with a single mouse approach in PK/PD bioanalysis
- An automated nanoliter-scale immunoassay platform
- Performance and productivity of ligand-binding assays
Drug metabolism and pharmacokinetic (DMPK) studies in support of drug candidate selection or regulatory submission are often challenging, with limited volumes available for analysis. Join Mark Cameron and Andreea Halford of MPI Research, along with Ann-Charlott Steffen of AstraZeneca, to explore the new developments of a single mouse approach in PK/PD bioanalysis, using an automated nanoliter-scale immunoassay platform, and its impact on redefining performance and productivity of ligand-binding assays in the early development of biotherapeutics. Click here to register for this webinar.